Noninvasive Oxygenation Strategies in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials

Journal of Intensive Care Medicine

Volumn 35, Issue 11, 2020, Pages 1216-1225

  Zayed, Yazan ^a   Banifadel, Momen ^b   Barbarawi, Mahmoud ^a   Kheiri, Babikir ^a   Chahine, Adam ^a   Rashdan, Laith ^a   Haykal, Tarek ^a   Samji, Varun ^a   Armstrong, Emily ^a   Bachuwa, Ghassan ^a   Al Sanouri, Ibrahim ^a   Seedahmed, Elfateh ^a   Hernandez, Dawn Alita ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c UNIVERSITY OF TOLEDO   (United States)

Author keywords

high flow nasal cannula; immunocompromised patients; meta analysis; noninvasive ventilation; respiratory failure

Indexed keywords

ACUTE RESPIRATORY FAILURE; ALL CAUSE MORTALITY; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; BAYES THEOREM; BLOOD OXYGEN TENSION; ELECTRONIC HEALTH RECORD; HIGH FLOW NASAL CANNULA THERAPY; HUMAN; HYPOXEMIA; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; META ANALYSIS; NONINVASIVE VENTILATION; OXYGEN SATURATION; OXYGEN THERAPY; OXYGENATION; QUALITY CONTROL; TIDAL VOLUME; FEMALE; MALE; MIDDLE AGED; NETWORK META-ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE;

FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; NETWORK META-ANALYSIS; NONINVASIVE VENTILATION; OXYGEN INHALATION THERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY INSUFFICIENCY;

EID: 85065401028     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066619844713     Document Type: Article

References (36)

1. Azoulay E, Mokart D, Pène F, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol. 2013;31(22):2810–2818. doi:10.1200/JCO.2012.47.2365.
2. Canet E, Osman D, Lambert J, et al. Acute respiratory failure in kidney transplant recipients: a multicenter study. Crit Care. 2011;15(2):R91. doi:10.1186/cc10091.
3. Harpaz R, Dahl RM, Dooling KL. Prevalence of immunosuppression among US adults, 2013. JAMA. 2016;316(23):2547–2548. doi:10.1001/jama.2016.16477.
4. Israni AK, Zaun D, Rosendale JD, Schaffhausen C, Snyder JJ, Kasiske BL. OPTN/SRTR 2016 annual data report: deceased organ donation. Am J Transplant. 2018;18(suppl 1):434–463. doi:10.1111/ajt.14563.
5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.21442.
6. Cortegiani A, Madotto F, Gregoretti C, et al. Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database. Crit Care. 2018;22(1):157. doi:10.1186/s13054-018-2079-9.
7. Contejean A, Lemiale V, Resche-Rigon M, et al. Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study. Ann Intensive Care. 2016;6(1):102. doi:10.1186/s13613-016-0202-0.
8. Ewig S, Torres A, Riquelme R, et al. Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU. Eur Respir J. 1998;12(1):116–122. http://www.ncbi.nlm.nih.gov/pubmed/9701425.
9. Conti G, Marino P, Cogliati A, et al. Noninvasive ventilation for the treatment of acute respiratory failure in patients with hematologic malignancies: a pilot study. Intensive Care Med. 1998;24(12):1283–1288. http://www.ncbi.nlm.nih.gov/pubmed/9885881.
10. Cortegiani A, Russotto V, Antonelli M, et al. Ten important articles on noninvasive ventilation in critically ill patients and insights for the future: a report of expert opinions. BMC Anesthesiol. 2017;17(1):122. doi:10.1186/s12871-017-0409-0.
11. Azoulay E, Mokart D, Kouatchet A, Demoule A, Lemiale V. Acute respiratory failure in immunocompromised adults. Lancet Respir Med. 2019;7(2):173–186. doi:10.1016/S2213-2600(18)30345-X.
12. Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2). doi:10.1183/13993003.02426-2016.
13. Antonelli M, Conti G, Bufi M, et al. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA. 2000;283(2):235–241. http://www.ncbi.nlm.nih.gov/pubmed/10634340.
14. Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med. 2001;344(7):481–487. doi:10.1056/NEJM200102153440703.
15. Dugan KC, Hall JB, Patel BK. High-flow nasal oxygen—the pendulum continues to swing in the assessment of critical care technology. JAMA. 2018. doi:10.1001/jama.2018.14287.
16. Cortegiani A, Crimi C, Sanfilippo F, et al. High flow nasal therapy in immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis. J Crit Care. 2019;50:250–256. doi:10.1016/j.jcrc.2018.12.015.
17. Sklar MC, Mohammed A, Orchanian-Cheff A, Del Sorbo L, Mehta S, Munshi L. The impact of high-flow nasal oxygen in the immunocompromised critically ill: a systematic review and meta-analysis. Respir Care. 2018;63(12):1555–1566. doi:10.4187/respcare.05962.
18. Huang HB, Peng JM, Weng L, Liu GY, Du B. High-flow oxygen therapy in immunocompromised patients with acute respiratory failure: a review and meta-analysis. J Crit Care. 2018;43:300–305. doi:10.1016/j.jcrc.2017.09.176.
19. Azoulay E, Pickkers P, Soares M, et al. Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med. 2017;43(12):1808–1819. doi:10.1007/s00134-017-4947-1.
20. Frat JP, Ragot S, Girault C, et al. Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial. Lancet Respir Med. 2016;4(8):646–652. doi:10.1016/S2213-2600(16)30093-5.
21. Huang HB, Xu B, Liu GY, Lin JD, Du B. Use of noninvasive ventilation in immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis. Crit Care. 2017;21(1):4. doi:10.1186/s13054-016-1586-9.
22. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi:10.1186/2046-4053-4-1.
23. Squadrone V, Massaia M, Bruno B, et al. Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Med. 2010;36(10):1666–1674. doi:10.1007/s00134-010-1934-1.
24. Wermke M, Schiemanck S, Höffken G, Ehninger G, Bornhäuser M, Illmer T. Respiratory failure in patients undergoing allogeneic hematopoietic SCT—a randomized trial on early non-invasive ventilation based on standard care hematology wards. Bone Marrow Transplant. 2012;47(4):574–580. doi:10.1038/bmt.2011.160.
25. Lemiale V, Mokart D, Resche-Rigon M, et al. Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA. 2015;314(16):1711–1719. doi:10.1001/jama.2015.12402.
26. Gupta S, Govil D, Srinivasan S, et al. High flow nasal cannula (HFNC) as an alternative to noninvasive ventilation (NIV) in acute respiratory failure (ARF) in immunosuppressed patients-an Indian post liver transplant experience. Intensive Care Med Exp Conf 29th Annu Congr Eur Soc Intensive Care Med ESICM 2016 Italy. 2016;4. doi:10.1186/s40635-016-0099-9.
27. Lemiale V, Mokart D, Mayaux J, et al. The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial. Crit Care. 2015;19:380. doi:10.1186/s13054-015-1097-0.
28. Azoulay E, Lemiale V, Mokart D, et al. Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial. JAMA. 2018. doi:10.1001/jama.2018.14282.
29. Carteaux G, Millán-Guilarte T, De Prost N, et al. Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure: role of tidal volume. Crit Care Med. 2016;44(2):282–290. doi:10.1097/CCM.0000000000001379.
30. Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369(22):2126–2136. doi:10.1056/NEJMra1208707.
31. Mokart D, Lambert J, Schnell D, et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma. 2013;54(8):1724–1729. doi:10.3109/10428194.2012.753446.
32. Burghi G, Lemiale V, Seguin A, et al. Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis. Intensive Care Med. 2011;37(10):1605–1612. doi:10.1007/s00134-011-2344-8.
33. Azoulay E, Lemiale V, Mokart D, et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med. 2014;40(8):1106–1114. doi:10.1007/s00134-014-3354-0.
34. Mokart D, van Craenenbroeck T, Lambert J, et al. Prognosis of acute respiratory distress syndrome in neutropenic cancer patients. Eur Respir J. 2012;40(1):169–176. doi:10.1183/09031936.00150611.
35. Girardis M, Busani S, Damiani E, et al. Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the oxygen-ICU randomized clinical trial. JAMA. 2016;316(15):1583–1589. doi:10.1001/jama.2016.11993.
36. Chu DK, Kim LHY, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with Liberal Versus Conservative Oxygen Therapy (IOTA): a systematic review and meta-analysis. Lancet (London, England). 2018;391(10131):1693–1705. doi:10.1016/S0140-6736(18)30479-3.